Abstract
Phosphatidylinositol 3-kinase α is an attractive target to potentially treat a range of cancers. Herein,
we described the evolution of a reported PI3K inhibitor into a moderate PI3Kα inhibitor with a low
molecular weight. We used X-ray crystallography to describe the accurate binding mode of the
compound YXY-4F. A comparison of the p110α–YXY-4F and apo p110α complexes showed that YXY-4F
induced additional space by promoting a fexible conformational change in residues Ser773 and Ser774
in the PI3Kα ATP catalytic site. Specifcally, residue 773(S) in PI3Kα is quite diferent from that of PI3Kβ
(D), γ (A), and δ (D), which might guide further optimization of substituents around the NH group and
phenyl group to improve the selectivity and potency of PI3Kα.
Original language | English |
---|---|
Article number | 14572 |
Pages (from-to) | 1-7 |
Journal | Scientific Reports |
Volume | 7 |
Early online date | 06 Nov 2017 |
DOIs | |
Publication status | Early online date - 06 Nov 2017 |